Pinealon

Description

Pinealon (EDR; L-glutamyl-L-aspartyl-L-arginine) is a synthetic tripeptide belonging to the family of short peptide bioregulators (cytomedins) developed through systematic fractionation of pineal gland extracts. Preclinical research has investigated its capacity to permeate the blood-brain barrier and modulate transcriptional activity in neural cell populations, with particular focus on genes involved in oxidative stress resistance and cellular longevity pathways.

In cellular and rodent model contexts, Pinealon 20mg has been studied for its influence on melatonin biosynthesis, circadian gene expression, and neurotrophic support in aging neural tissue. Research programs deploy it as a probe of epigenetic and transcriptional mechanisms within pinealocytes, neurons, and glial cells, contributing to a broader mechanistic understanding of neuroendocrine aging biology and peptide bioregulator pharmacology. For laboratory research use only. Not for human or veterinary use.